Intuitive Surgical, Inc. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
Intuitive Surgical, Inc. (ISRG) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $17.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2026-07-21
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2026-06-30 was $17.30M, a 47.42% decline year-over-year.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2026-03-31 was $73.30M, a 49.59% decline year-over-year.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2025-09-30 was $24.20M, a 42.65% decline year-over-year.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2025-06-30 was $32.90M, a 7.84% decline year-over-year.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was -$223.30M.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was -$107.90M.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2022 was -$98.70M.
- Intuitive Surgical, Inc. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2021 was -$185.80M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month as first filed | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17.30M 10-Q · filed 2026-07-21 | $90.60M 10-Q · filed 2026-07-21 | ||||
| 2026-03-31 | $73.30M 10-Q · filed 2026-04-22 | |||||
| 2025-09-30 | $24.20M 10-Q · filed 2025-10-22 | $202.50M 10-Q · filed 2025-10-22 | ||||
| 2025-06-30 | $32.90M 10-Q · filed 2026-07-21 | $178.30M 10-Q · filed 2026-07-21 | ||||
| 2025-03-31 | $145.40M 10-Q · filed 2026-04-22 | |||||
| 2024-12-31 | -$223.30M 10-K · filed 2026-02-03 | |||||
| 2024-09-30 | $42.20M 10-Q · filed 2025-10-22 | $189.00M 10-Q · filed 2025-10-22 | ||||
| 2024-06-30 | $35.70M 10-Q · filed 2025-07-23 | $146.80M 10-Q · filed 2025-07-23 | ||||
| 2024-03-31 | $111.10M 10-Q · filed 2025-04-23 | |||||
| 2023-12-31 | -$107.90M 10-K · filed 2026-02-03 | |||||
| 2023-09-30 | $22.00M 10-Q · filed 2024-10-18 | $86.20M 10-Q · filed 2024-10-18 | ||||
| 2023-06-30 | $41.70M 10-Q · filed 2024-07-19 | $64.20M 10-Q · filed 2024-07-19 | ||||
| 2023-03-31 | $22.50M 10-Q · filed 2024-04-19 | |||||
| 2022-12-31 | -$98.70M 10-K · filed 2025-01-31 | |||||
| 2022-09-30 | $18.10M 10-Q · filed 2023-10-20 | $80.40M 10-Q · filed 2023-10-20 | ||||
| 2022-06-30 | $9.30M 10-Q · filed 2023-07-24 | $62.30M 10-Q · filed 2023-07-24 | ||||
| 2022-03-31 | $53.00M 10-Q · filed 2023-04-20 | |||||
| 2021-12-31 | -$26.90M 10-K · filed 2022-02-03 | -$185.80M 10-K · filed 2024-01-31 | ||||
| 2021-09-30 | $41.90M 10-Q · filed 2022-10-21 | $158.90M 10-Q · filed 2022-10-21 | ||||
| 2021-06-30 | $43.60M 10-Q · filed 2022-07-22 | $117.00M 10-Q · filed 2022-07-22 | ||||
| 2021-03-31 | $73.40M 10-Q · filed 2022-04-22 | |||||
| 2020-12-31 | -$21.30M 10-K · filed 2022-02-03 | $21.30M 10-K · filed 2021-02-10 | -$166.20M 10-K · filed 2023-02-10 | $166.20M 10-K · filed 2021-02-10 | ||
| 2020-09-30 | -$47.90M 10-K · filed 2022-02-03 | $47.90M 10-K · filed 2021-02-10 | $144.80M 10-Q · filed 2021-10-20 | |||
| 2020-06-30 | -$31.60M 10-K · filed 2022-02-03 | $31.60M 10-K · filed 2021-02-10 | $97.00M 10-Q · filed 2021-07-21 | |||
| 2020-03-31 | -$65.40M 10-K · filed 2022-02-03 | $65.40M 10-K · filed 2021-02-10 | ||||
| 2019-12-31 | $33.70M 10-K · filed 2021-02-10 | -$146.50M 10-K · filed 2022-02-03 | $146.50M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $28.80M 10-K · filed 2021-02-10 | |||||
| 2019-06-30 | $11.30M 10-K · filed 2021-02-10 | |||||
| 2019-03-31 | $72.70M 10-K · filed 2021-02-10 | |||||
| 2018-12-31 | $15.80M 10-K · filed 2020-02-07 | $116.20M 10-K · filed 2021-02-10 | ||||
| 2018-09-30 | $24.10M 10-K · filed 2020-02-07 | |||||
| 2018-06-30 | $21.60M 10-K · filed 2020-02-07 | |||||
| 2018-03-31 | $54.70M 10-K · filed 2020-02-07 | |||||
| 2017-12-31 | $102.80M 10-K · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |